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ABSTRACT
International Journal of Exercise Science 12(2): 187-202, 2019. Multiple ingredient pre-workout
supplements (MIPS) are purported to offer favorable acute metabolic changes potentially leading to improvements
in body composition and training adaptations over time. However, there is limited information available regarding
the long-term benefits and safety of consuming MIPS, specifically in female populations. Therefore, the purpose of
this study was to investigate the effects of pre-workout ingestion on body composition, training adaptations and
select markers of clinical health in recreationally active females after 7 weeks of supplementation and resistance
training. Nineteen participants participated in a randomized, double-blind, placebo controlled study. Experimental
testing included resting heart rate and blood pressure, blood lipid panels, body composition, resting metabolic
testing and performance measurements before and after a seven-week resistance training program while ingesting
either a MIPS or placebo once daily. There were no significant group x time interactions for changes in body fat
percentage (p=0.66), fat-free mass (p=0.87), fat mass (p=0.63) or resting metabolic rate (p=0.52). Both groups showed
significant improvements in upper (p<0.001) and lower body (p<0.001) maximal strength following the 7-week
training period however no differences in upper (p=0.74) and lower body (p=0.53) strength improvements were
observed between groups, respectively. No significant group x time interactions were observed for any of the
markers of clinical health. In conclusion, the current study suggests that daily consumption of a MIPS does not
enhance training adaptations in recreationally active females and does not appear to negatively affect resting blood
pressure, heart rate and blood lipids.
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INTRODUCTION
The use of dietary supplements to enhance exercise performance and improve body
composition is becoming a popular strategy among active individuals. A particular class of
dietary supplements referred to as multi-ingredient pre-workout supplements (MIPS) are a type
of supplement designed to be consumed prior to an exercise bout with the presumption they
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will enhance the quality of that training session thereby potentially leading to an augmentation
of training adaptations over time. These products often contain a variety of ingredients, which
include but not limited to, caffeine, taurine, beta-alanine, creatine, amino acids and various
herbal extracts. Several of these ingredients have well-researched and supported benefits, which
can include enhanced energy availability, improved maximal strength, increased energy
expenditure, enhanced buffering capacity of skeletal muscle and improved focus (4, 5, 7, 12, 13,
16, 36, 37, 39, 42); via their respective mechanisms of action. The wide variety of purported
benefits and ingredient lists often make these products potentially advantageous for a variety
of exercise or nutrition-related goals. Several investigations have examined the impact of MIPS
ingestion on acute measures of exercise performance with positive results following just a single
dose (4, 6, 13, 17, 39). Specifically, it appears as though acute ingestion of these supplements
prior to a training session may improve training volume, anaerobic performance and subjective
markers of fatigue and energy (6, 8, 13, 15, 17). These acute improvements in exercise
performance and perceived workout quality may lead to enhanced training adaptations over
time when combined with a structured training program. For example, Ormsbee et al. (24)
reported significantly greater improvements in anaerobic power in those supplementing with a
MIPS and following a resistance training program for a six-week period. Other studies have also
reported enhanced training adaptations over time following MIPS supplementation in
conjunction with a resistance training program (23, 34). However, the majority of this research
has focused primarily on males.
In addition to enhancing exercise performance, some manufacturers also make claims of
enhanced fat loss and improved body composition resulting from the thermogenic properties of
specific MIPS ingredients (1, 10, 27). There is some supporting evidence of this purported benefit
within the literature as acute elevations in energy expenditure following supplementation have
been reported (6, 8). As evidenced, Campbell et al. (8) observed acute increases in resting
metabolic rate at 60, 120, and 180 minutes post ingestion of a thermogenic supplement (similar
in nature to a MIPS) when compared to placebo. Additionally, Rashti et al. (30) reported
significant increases in oxygen consumption and energy expenditure in young active females
following ingestion of an energy drink. However, it is important to note that acute elevations in
energy expenditure may not necessarily translate to significant reductions in body mass or fat
mass over time. As it stands today, there is limited evidence to suggest that long-term
consumption of a MIPS will favorably alter body composition over time when combined with
an exercise program of some kind, particularly across a wide-spectrum of populations (22, 25,
34, 37). Ormsbee et al. (24) were the first to note greater increases in lean body mass in resistancetrained males supplementing with a MIPS compared to placebo, following a six week resistance
training and supplementation program. Similar improvements in lean body mass were seen
following daily pre and post-workout ingestion of a MIPS after a six week training program
(26). However, as mentioned previously the majority of these investigations have utilized
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resistance-trained males as a subject group and therefore may not translate well across multiple
populations, particularly in lesser-trained females.
Not only is it important to examine the efficacy of such supplements, it is also important to
investigate the safety of these products as several contain various amounts of stimulants and
herbal extracts. As a result, the degree to which they influence markers of clinical health, is
currently unknown; particularly when consumed for extended periods or in high dosages as
there is a paucity of research in this area. There are currently mixed results within the literature
regarding any adverse effects following ingestion of a single dose of MIPS. Commonly reported
adverse effects often include nausea, paresthesia, dizziness, headache and shortness of breath
following ingestion (34); some of which are common side-effects of caffeine (12) and beta-alanine
(42), two common MIPS ingredients. Previous research indicates that long-term MIPS
supplementation does not appear to negatively influence biomarkers of clinical health or
cardiovascular health measures in males (18, 25, 34, 38). However, currently there is limited data
available regarding the long-term health implications of consuming MIPS in females with the
exception of one study which did not detect any abnormal changes in hematological markers or
resting vital signs after 28 days of MIPS supplementation even when participants ingested twice
the recommended serving size (43).
Previous research has indicated that regular resistance training is an effective modality to
improve body composition in females (19, 31). Therefore, with the available evidence regarding
the acute benefits of MIPS ingestion and the limited data regarding long-term improvements
from MIPS supplementation in males, it is plausible that consuming MIPS in conjunction with
the completion of a resistance training program could also enhance training adaptations in
females. However, currently these benefits, in addition to the safety of MIPS supplementation
over an extended period (>4 weeks), have yet to be examined. Therefore, the purpose of this
study was to examine the effects of 7 weeks of resistance training with supplementation of a
MIPS on exercise performance, body composition, resting metabolism, blood lipids and resting
vitals health in young active females.
METHODS
Participants
Twenty-nine recreationally active females between the ages of 18-30 were initially recruited to
participate in this study. Seven participants removed themselves from the study citing time
conflicts and three removed themselves because of a lack of interest in the training program.
Recreationally active was defined as having participated in at least 150 min of moderate activity
per week for at least six months based on the guidelines by the American College of Sports
Medicine (29). Participants could not have any contradictions to participation according to their
medical history questionnaire. These contradictions included metabolic disorders, heart disease,
arrhythmias, diabetes, thyroid disease, hypertension, hepatorenal, musculoskeletal,
autoimmune, or neurological disease. Further exclusion criteria included those currently taking
thyroid, anti-hyperlipidemic, hyperglycemic, anti-hypertensive, or anti-inflammatory
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medications. Participants were also not allowed to participate if they had taken nutritional or
ergogenic supplements three weeks prior to testing, or have lost or gained more than 4.5kg over
the previous thirty days. All participants provided informed consent in compliance with the
Human Participants Guidelines and the Institutional Review Board of the University of
Wisconsin – La Crosse.
Protocol
This study utilized a randomized, double blind, placebo controlled design. After participant
recruitment, participants attended an informational meeting to learn about the requirements of
their participation, to provide written informed consent and complete demographic and health
history forms. All participants then completed a baseline testing session, which included
measurements of blood lipids, resting vitals, body composition, resting metabolism, and
strength testing. Participants were instructed to report to the lab in a fasted (>8 hours) state with
no prior exercise (>24 hours). After baseline testing, participants were randomly assigned to one
of two groups to consume one serving of supplement (MIPS) or placebo (P), daily for seven
weeks while completing a resistance training program and following their normal dietary
habits. All participants also completed weekly side effect questionnaires and daily supplement
logs to ensure supplement compliance. Following the seven-week supplementation period
(within 4 days of final training session), participants returned to the lab for post-testing under
similar conditions and did not consume their respective treatment on the day of testing.
Resting vitals and blood lipids: during baseline testing, resting blood pressure and heart rate
were first assessed using standard clinical procedures. Blood samples were collected from
fingertip to be analyzed for blood lipids. Once the finger was sterilized a Unistik 2 (Marietta,
GA) lancet was used to withdraw blood. Samples were then immediately analyzed for highdensity lipoprotein (HDL-C), low-density lipoprotein (LDL-C), total cholesterol (TC) and
triglyceride levels using an Alere Cholestech LDX® (AlereTM, Waltham, MA, USA) analyzer.
This point of care analyzer has previously been shown to be a valid measure of blood lipids and
results are highly correlated with values provided by the National Health Laboratory Service
Controls (r = 0.94, r = 0.98, r = 0.87, r = 0.94 for total cholesterol, triglycerides, HDL cholesterol
and LDL cholesterol, respectively) (28). Quality control measures were run daily according to
the manufacturer instructions. Optics checks and calibration protocols were completed between
each subject. Participants with triglyceride levels less than 45 mg/dl did not register on the
blood panel, therefore a value for low-density lipoprotein could not be calculated. In order to
derive such a value, participants who had a triglyceride measurement lower than 45 mg/dl (n
= 5) a value of 45 mg/dl was used in order to derive their LDL using the Friedewald equation,
which has been validated by Tremblay et al. (41). The following equation was used: ([LDL-C=
(TC) – (HDL-C) - ([TG]/5)).
Body Composition and Metabolic Testing: height and body mass were measured using a
Healthometer (Telstar LLC, Bridgeview, IL) scale. Resting metabolic rate (RMR) was assessed
using indirect calorimetry via a TrueOne 2400 metabolic measurement system (ParvoMedics,
Sandy, UT) in rested and fasted state. This test required participants to lie in a supine position
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with a clear, plastic hood over their neck and head to determine resting oxygen uptake and
energy expenditure. This test was approximately twenty minutes long with data being collected
after the first fifteen minutes, during a period of five minutes when criterion variables changed
less than 5%. Equipment was calibrated prior to testing and in-between every five participants.
Following RMR testing, participants had their body composition assessed using air
displacement plethysmography (BODPOD, Cosmed, USA). Body fat percentage, fat mass (FM),
and fat-free mass (FFM) were assessed using body densities obtained from the BODPOD. To
increase test accuracy, standardized volume calibrations were completed before each test.
Additionally, participants were instructed to wear only compression shorts, sports bras, and a
lycra swim cap during testing.
Strength Testing: following resting measurements, participants completed a ten-minute warmup consisting of a two-minute, comfortable jog and several dynamic exercises that targeted
major muscle groups of the upper and lower body. After warming up, participants completed a
counter-movement vertical jump (CMVJ) test using the Just Jump System (Sports, Imports,
Columbus, OH). The participants were allowed two attempts using less than maximal effort for
practice. Three maximum effort CMVJ attempts were then recorded, each separated by two
minutes of rest. Another attempt was allowed if the third attempt was greater than the first
three. Attempts were continued until there was a decrease in jump height observed. No more
than five CMVJ attempts were allowed. The best jump height was recorded and used for
analysis.
All participants then completed maximal strength testing for the bench press and leg press
exercises. A standard isotonic leg press and Olympic bench press (Hammer Strength, Life
Fitness, USA) were used to test maximal strength for the participants' one-repetition maximum
(1 RM). Prior to beginning 1RM attempts, participants completed a standardized warm-up
consisting of ten repetitions at 50% of their estimated 1RM. For testing, weight was progressively
added until a 1RM was acquired, with two minutes of rest in between each maximal attempt.
The participants first did maximal strength testing on the leg press, then followed by four
minutes of rest, began warming up on the bench press for maximal strength testing. Bench press
1RM testing followed the same procedures as the leg press 1RM test. Four minutes after testing
maximal strength, muscular endurance tests were completed based on the participants' recently
assessed 1RM for both upper and lower body exercises. The participants were instructed to
complete as many repetitions as possible at 75% of their established 1RM until failure for the leg
press and the bench press exercises, respectively. Only one attempt was given for each exercise.
Participants rested for four minutes between the leg press and bench press tests.
Supplementation and Dietary Protocols: following baseline testing, participants were randomly
assigned to either the supplementation group (MIPS) or placebo (PL) group. The
supplementation group consumed a single serving of a commercially available MIPS
(MusclePharm, Fitmiss™ Ignite™), while the control group consumed a placebo of similar
texture and taste that was prepared by the supplement manufacturer. Participants were
instructed to consume one scoop (7.5g), of the supplement or placebo, mixed with 14-16 oz. of
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water. Participants were instructed to consume one serving thirty minutes before each exercise
session and one serving following breakfast on recovery days. Participants did not consume
their designated supplement on the day of post-testing. Figure 1 provides a detailed list of the
supplement ingredients. Participants were instructed to follow their normal dietary habits and
to record their daily food intake using a commercially available nutrition tracking system
(MyFitnessPal Inc., USA). Mean weekly energy intake values were later calculated.
Resistance Training Program: participants were instructed to complete a resistance training
program during the 7-week supplementation period. Training sessions consisted of full-body
exercises, with various upper body push (i.e. barbell bench press, dumbbell presses, pushups,
overhead presses, etc.), upper body pull (i.e. dumbbell rows, machine rows, lat pulldowns,
assisted pull-ups, etc.), lower body push (i.e. barbell squats, goblet squats, leg press, lunges,
etc.), lower body pull (i.e. deadlift variations, reverse lunges, hip thrusts, leg curls, etc.) and core
stabilization movements. These exercises were completed with short rest intervals (~60 sec). A
variety of equipment was used including: kettlebells, Olympic bars and plates, dumbbells,
medicine balls, resistance bands, and body weight exercises. Participants completed three
exercise sessions per week, each lasting approximately one hour. One of the three weekly
sessions was completed using solely body weight exercises with no equipment necessary to
allow flexibility for the participants’ schedules. Each session consisted of a 5-10-minute warmup, 8-10 full-body exercises, followed by a 5-10 minute cool down. Each exercise was completed
for three sets of 10-12 repetitions with 90 seconds of rest in between sets. Participants followed
a modified linear periodization model. Briefly, as
training volume decreased from one week to the next
within a microcycle, the load was concomitantly
increased to satisfy the progressive overload principle of
training and elicit the desired training adaptations. Load
and rates of progression were self-selected by the
participants based on ratings of difficulty. Participants
were instructed to choose a load that resulted in the final
two repetitions of each set being difficult, but not
impossible to complete. As the number of repetitions
decreased throughout the program, participants were
instructed to increase the load to maintain the required
level of difficulty. Participants recorded all workouts
which were later analyzed for total training-load
volume (sets x reps x weight lifted for all exercises)
completed during each week and compared between
groups.
Statistical Analysis
Statistical analysis was completed using the software Statistical Package for the Social Sciences
(SPSS Inc., Chicago, IL). Baseline values were assessed using an independent t-test to ensure
statistical equality between the groups. Post testing results were assessed with a two-way (group
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x time) mixed factorial analysis of variance (ANOVA) to determine group differences in body
fat percentage, FM, FFM, RMR, markers of clinical health and exercise performance. Alpha was
set at p<0.05 to achieve statistical significance for all tests. If statistical difference was found, a
Tukey’s post-hoc test was completed to determine where between group significance occurred.
All data are presented as mean ± SD.
RESULTS
Nineteen total participants (MIPS; n = 9; PL; n=10) completed the study. Descriptive statistics
for those who completed the study are represented in Table 1.
Table 1. Descriptive statistics of participants
Variable
MIPS (n=9)
Age (yrs.)
20.3 ± 0.5
Height (cm)
169.9 ± 4.8
Weight (kg)
67.8 ± 7.5
Body Fat % (%)
29.1 ± 6.8
Data presented as mean + SD

PL (n=10)
19.6 ± 0.8
169.9 ± 5.8
66.3 ± 9.5
28.0 ± 7.3

Resting Vitals and Blood Lipids: Table 2. presents a summary of changes observed in heart rate,
blood pressure and blood lipids after 7-weeks of supplementation and training. No significant
group x time interactions were observed for resting heart rate (p = 0.43), systolic blood pressure
(p = 0.18), or diastolic blood pressure (p = 0.20).
Table 2. Changes in resting heart rate and blood pressure
Variable
Pre
Resting Heart Rate
(bpm)
MIPS
83.4 ±15.8
PL
77.0 ± 10.0
Systolic Blood Pressure
(mmHg)
MIPS
114.7 ± 10.4
PL
109.6 ± 7.1
Diastolic Blood Pressure
(mmHg)
MIPS
71.3 ± 9.5
PL
67.4 ± 6.1
Data presented as mean + SD

Post
84.6 ± 17.9
81.7 ± 16.3
108.4 ± 11.8
108.4 ± 5.7
63.6 ± 6.9
63.8 ± 6.9

Blood lipid panel results: a significant difference in triglycerides was observed at baseline
between groups, as a result pre-testing measurements were used as a covariate to compare
differences in triglycerides over time. No significant group x time interactions were observed
for any of the blood lipid panel measurements as seen in Table 3.
Body Composition and Resting Metabolic Rate: Table 4. presents a summary of body
composition and resting metabolic changes. No group x time interactions were observed
regarding changes in body fat percentage (p = 0.67), FFM (p = 0.87), or FM (p = 0.63). No
significant group x time interaction (p = 0.52) was observed regarding changes in RMR.
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Table 3. Blood lipid panel results
Variable
Pre
Post
Triglycerides
(mg/Dl)
MIPS
60.6 ±31.6
73.9 ± 20.6
PL
95.9 ± 28.5+
99.9 ± 57.2
LDL-C
(mmol/L)
MIPS
77.9 ± 26.0
78.6 ± 30.6
PL
83.7 ±27.5
83.8 ± 31.3
HDL-C
(mmol/L)
MIPS
59.4± 19.1
62.6 ± 19.5
PL
54.8 ±14.6
57.5 ± 13.1
Total Cholesterol
(mmol/L)
MIPS
152.0 ±33.5
156.0 ± 38.4
PL
157.4 ± 24.6
161.3 ± 34.4
Data presented as mean + SD. +Denotes significant difference between groups.
Table 4. Changes in body composition and resting metabolic rate
Variable
Pre
Mid
Body Fat %
MIPS
29.1 ± 6.7
27.7 ± 7.4
PL
28.0 ± 7.3
26.2 ± 9.2
Body Mass (kg)
MIPS
67.8 ±7.5
68.2 ± 6.6
PL
66.3 ± 9.5
66.8± 10.2
Fat-free mass (kg)
MIPS
47.8 ± 6.3
49.2 ± 6.2
PL
47.2 ± 5.2
48.3 ±5.4
Fat mass (kg)
MIPS
19.7 ± 5.4
19.0 ± 5.7
PL
18.9 ± 7.3
18.6 ± 8.0
RMR (kcal/d)
MIPS
1,631.6 ± 189.6
NA
PL
1,597.6 ± 117.9
NA
Data presented as mean + SD

Post
27.6 ± 6.8
27.2 ± 8.2
68.1 ± 6.6
66.7 ± 6.6
49.0 ± 5.9
48.0 ± 5.3
18.8 ± 5.3
18.7 ± 8.1
1,710.6 ± 121.1
1,621.3 ± 153.7

Strength and Power Performance: Table 5. presents a summary of performance related variables.
Although both groups showed significant improvements in upper body and lower body
maximal strength (p < 0.05), there were no significant group x time interactions observed as seen
in Table 5. No significant group x time interactions were observed for any of the other
performance variables. There were no significant differences in training load volume completed
by each group during week one (p=0.10), week three (p=0.85), or week seven (p=0.89).
Dietary intake and side effects: no significant differences were observed for weekly mean energy
intakes between groups as presented in Table 6. Reported side effects included symptoms of a
“tingling” (n=2) sensation and itching in the face and/or hands (n=3) after ingestion of the MIPS.
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Table 5. Comparison of performance measures between groups
Variable
Pre
Post
CMVJ (cm)
MIPS
43.3 ± 7.5
44.5 ± 9.2
PL
43.4 ± 6.8
44.3 ± 6.9
Bench Press 1RM (kg)
MIPS
38.3 ± 8.5
41.1 ± 5.4*
PL
37.4 ± 9.5
39.7 ± 9.4*
Leg Press 1RM (kg)
MIPS
173.6 ± 36.5
196.8 ± 38.8*
PL
184.6 ±31.2
200.9± 36.1*
Bench Press to Failure (reps)
MIPS
10.8 ± 4.8
10.6 ± 2.5
PL
11.3 ± 2.7
13.0 ± 4.2
Leg Press to Failure (reps)
MIPS
13.6 ± 4.7
16.1 ± 4.9
PL
17.2 ± 6.1
17.8 ± 6.4
Data presented as mean + SD. *Denotes a significant main effect of time (p<0.05)
Table 6. Weekly mean energy intake (kcal/d)
Group
Week 1
MIPS
1,737 ± 276
Placebo
1,465 ± 196
All
1,593 ± 269
Data presented as mean + SD

Week 3
1,598 ± 252
1,547 ± 255
1,571 ± 247

Week 7
1,509 ± 257
1,490 ± 223
1,499 ± 232

DISCUSSION
The primary aim of the current study was to examine the effects of ingesting a MIPS on select
markers of clinical health, body composition, training adaptations and RMR in recreationally
active females completing a 7-week resistance training program. Results of the current study
suggest that supplementation with a MIPS designed for females does not result in any
augmentation of training adaptations or changes in body composition and metabolism
following 7-weeks of resistance training beyond those accomplished from resistance training
alone. The results of the current study serve as a follow-up to Cameron et al. (6) which examined
the acute effects of an identical MIPS product on exercise performance and resting metabolism.
Cameron and associates (6) observed significant elevations in RMR and improvements in upper
body muscular endurance, and sprint performance with participants reporting improved focus.
The authors speculated that the observed acute effects may help facilitate enhanced training
adaptations if MIPS supplementation was continued and used in conjunction with a resistance
training program. However, that hypothesis was not supported by the results of the current
study. The same MIPS was also investigated by Vogel et al. (43) who reported no abnormal
changes in hematological markers or resting vital signs among a similar population as that used
within the current study. Together, these results suggest that this particular MIPS does not
appear to adversely affect select markers of clinical health but may not improve training
adaptations within this type of population over a 7-week period.
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While ingestion of a MIPS may transiently increase RMR in the short term as was observed
previously by Cameron et al. (6) this does not appear to translate to any sustained increases in
RMR over time, particularly when RMR is assessed in the absence of MIPS ingestion as was the
case in the current study. Because chronic MIPS supplementation does not appear to influence
RMR, this likely explains the lack of any significant changes in body composition, particularly
fat loss. In agreement with the current findings, Ormsbee et al. (25) also did not observe any
significant changes in body composition or fat mass following an 8 week supplementation
period with a MIPS. Conversely, others have found significant improvements in body
composition, predominantly reductions in body fat (22, 27). An important factor that needs to
considered when various MIPS products are compared is the ingredient profile. As an example,
the dose of caffeine in various MIPS products may serve as a potential cause for differing
outcomes between studies, particularly when examining changes in body composition or RMR
over time due to its thermogenic properties (1, 3) and subsequent potential to increase daily
energy expenditure over the long-term. As with any class of dietary supplements, there are
several different ingredients in varying amounts often included in MIPS. Further, the ingredient
profiles are often listed as “proprietary blends” and therefore the specific ingredients amounts
are not always disclosed (11). These discrepancies may account for the mixed results reported
in the literature regarding long-term changes in RMR and body composition following longterm MIPS use. Proprietary blends present challenges when comparing different MIPS products
utilized in various studies.
In the current study, MIPS supplementation did not enhance strength measures or FFM beyond
that of resistance training alone, suggesting that ingestion of a single daily serving of a MIPS
does not enhance training adaptations when taken over a seven-week period. Both groups did
demonstrate increases in one repetition maximum strength for both upper and lower body while
no changes were observed for muscular endurance. Again, returning to the results previously
reported by Cameron et al. (6), which indicated acute MIPS can improve exercise performance,
the results of the current study suggest that acute MIPS benefits do not appear to translate to an
augmentation of training adaptations with continued use. The ability of a MIPS to amplify
training adaptations when combined with a structured training program appears to be
somewhat unclear within the literature. Ormsbee et al. (24, 26) reported no significant
improvements in upper or lower body strength in resistance-trained males after 6 weeks of
supplementing with a MIPS while completing a structured training program. Conversely,
Spillane et al. (38) observed significantly greater increases in upper and lower body strength
following 28 days of resistance training while consuming pre and post-multi-ingredient
supplementation. Several other MIPS supplementation studies also reported significant
improvements in exercise performance including improvements in muscular endurance,
maximal strength and power (23, 33, 34, 44). These inconsistencies within the literature are again
likely attributable to differences in ingredient profiles across products, length of each
supplementation period or from differences in training regimens and the training status of
participants. Additionally, some of the aforementioned studies were as short as 4 weeks whereas
others were as long as 9 weeks. Depending on the mechanism of action of the various ingredients
and the training status of the individuals, the length of supplementation periods may also
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influence differences in training outcomes. Finally, certain products may also contain
ingredients that are designed more for eliciting increases in muscle hypertrophy and strength
such as creatine, beta-hydroxy-beta-methylbuterate or various amino acids (21). However, some
products may contain ingredients that are more focused on promoting weight loss through
different thermogenic or lipolytic mechanisms such as caffeine, green tea extract and L-carnitine
(21). Although the amount of caffeine in the current MIPS was not listed on the ingredient label,
it was specifically designed for women and likely contained a lower caffeine content than a
similar MIPS intended for males. Therefore, the caffeine content or other ingredient amounts, in
the current MIPS may have been below the recommended threshold required (12) to confer any
ergogenic value when ingested over time; as the post-testing was conducted in the absence of
the MIPS.
It appears that long-term supplementation of MIPS does not appear to negatively influence
cardiovascular health measures in males (18, 25, 34, 38). However, there is limited data available
regarding the long-term health implications of consuming MIPS in females. To date, Vogel et al.
(43) are the only group that has examined the effects of extended MIPS ingestion on resting
hemodynamic variables in females which is pertinent to the current study as the same MIPS was
studied. Vogel et al. (43) did not detect any abnormal changes in resting vital signs after 28 days
of MIPS supplementation even when participants ingested twice the recommended serving size.
Results of the current study suggest that a longer supplementation period (7 weeks) with the
same MIPS also does not appear to elicit any serious adverse effects when consumed daily.
Specifically, MIPS supplementation did not appear to alter resting or systolic blood pressure.
However, diastolic blood pressure was found to be lower at the conclusion of the study in the
MIPS group compared to placebo, though this difference was not statistically significant.
Previous studies have observed decreases in DBP after long-term supplementation with a MIPS
or caffeinated product (9, 18) which is somewhat contradictory as one of the primary active
ingredients in MIPS, caffeine, stimulates sympathetic activity which can lead to increased heart
rate and blood pressure immediately following ingestion. However, it is important to note that
when the participants were tested at pre and post-testing, they abstained from consuming their
designated supplement and therefore were not influenced by any residual sympathomimetic
effect of previously consumed caffeine as the half-life of caffeine is 4-6 hours. (2). The posttesting protocol (with or without MIPS ingestion the day of) is an important factor when
interpreting MIPS supplementation results. Some MIPS, the current one included, also contain
beetroot extract, which is high in nitrate content and has been shown to reduce blood pressure
by increasing vasodilation through increased nitric oxide production (14, 35). However, without
knowing the exact amount of beetroot extract within the MIPS it is difficult to infer whether
MIPS consumption may influence long-terms changes in blood pressure. More research is
needed to determine the impact of chronic MIPS supplementation on different cardiovascular
parameters as MIPS are a class of dietary supplements that often contain high amounts of
caffeine or other stimulatory agents that could be problematic for certain populations.
In the current study, no statistically significant differences were found between groups for lipid
panel measurements following the 7-week supplementation period. Similar results have been
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observed in previous studies, which investigated the effects of MIPS ingestion on various whole
blood and serum markers of clinical health (25, 34, 38, 43). Especially worth noting, is the
previously mentioned study by Vogel et al. (43) who reported no significant changes in clinical
health markers even when two servings of a MIPS (the same product used in the current study)
were consumed daily for a 28 day period. While not statistically different, there was a trend
towards increased HDL-C levels in both groups over the seven-week period in the current
study. It is known that regular aerobic and resistance training can lead to modestly raised HDLC and lower LDL-C levels (20). However, this is not a one size fits all method and positive
changes in lipid panel results resulting from exercise may vary based on baseline triglyceride
and HDL-C levels as well as physiologic characteristics of each individual person (20).
Differences in certain vitamins and minerals or other nutritional components may also influence
certain health-related outcomes and therefore the lack of detailed information regarding
macronutrient and micronutrient intakes throughout the duration of the study is a limitation of
the current design. Further, it is possible that participants under-reported energy intakes,
particularly as the measured RMR values are fairly similar to reported energy intake.
Unfortunately, inadequate dietary reporting is always a risk with self-reported dietary intakes
(32). In an attempt to address this issue, all participants received instructional training on how
to accurately assess and enter all food consumed throughout the study period. Further,
MyFitnessPal has been shown to be a valid tool to assess dietary intake (40).
There is limited evidence of any non-cardiovascular or hematological-based adverse effects from
MIPS supplementation. Shelmadine et al. (34) reported that participants supplementing with
MIPS experienced side effects including nausea, dizziness, headache and shortness of breath
following ingestion acute ingestion. Other studies have reported a “tingling sensation” and
“itchiness” following MIPS ingestion (6, 43) which is likely attributable to the beta-alanine
contained within the products (42) and does not impose any serious health risks. Participants in
the current study also reported occasional sensations (paresthesia-like) that were similar in
description to previous reports, which have investigated beta-alanine containing products.
In conclusion, daily supplementation with a MIPS for 7 weeks in conjunction with a training
program does not appear to enhance training adaptations nor elicit any positive changes in body
composition in an active female population, completing resistance training 3 times per week at
the current recommended dosage. MIPS ingestion was not associated with any negative
hematological or metabolic side effects in recreationally active females. Further, minimal side
effects and no significant deleterious effects on markers of clinical health were detected
following supplementation. More research examining the effects of different MIPS products and
training protocols in an active female population is warranted because of the lack of studies
being done with this population.
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